Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2025-12-24 @ 2:15 PM
NCT ID:
NCT02780895
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of idiopathic PD with tremor, rigidity or hypokinesia as major symptoms.
* A two to twenty-five-year history of PD with significant medical management or difficulty in medical management.
* A definite response to levodopa compounds with inadequately relieved of symptoms, or severe secondary effects of the drug.
* Good general health.
* A strong will or desire to have the procedure after being fully informed of its experimental nature.
Exclusion Criteria:
* History of repeated strokes with stepwise progression of parkinsonian features
* History of repeated head injury
* History of definite encephalitis
* Oculogyric crises (unless drug-induced)
* Neuroleptic treatment at onset of symptoms
* Supranuclear gaze palsy
* Cerebellar signs
* Babinski sign
* Presence of cerebral tumor or communicating hydrocephalus on CT scan
* Sustained remission or negative response to an adequate dose of levodopa
* Patients with parkinsonism other than Idiopathic PD
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02780895
Study Brief:
Protocol Section:
NCT02780895